EGFR and colorectal carcinoma: Present findings provide EGF-NIR as an enabling platform technology for possible implementation of the binding protocol to visualize ex vivo EGFR in human CRC tissue, complementary to the gold standard technique of RT-PCR for EGFR mRNA quantification [6], in situ hybridization [8] and EGFR immunohistochemistry [7].